Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-25-102276
Filing Date
2025-08-04
Accepted
2025-08-04 20:00:05
Documents
2
Period of Report
2025-07-16

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 13921
2 EX-24 srpt-ex24.htm EX-24 11217
  Complete submission text file 0000950170-25-102276.txt   26835
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Issuer) CIK: 0000873303 (see all company filings)

EIN.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 215 FIRST STREET CAMBRIDGE MA 02140
Business Address
Wong Ryan Ho-Yan (Reporting) CIK: 0002079673 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-14895 | Film No.: 251182340